Skip to main content
Log in

L-Theanine-Treated Adipose-Derived Mesenchymal Stem Cells Alleviate the Cytotoxicity Induced by N-Nitrosodiethylamine in Liver

  • Original Article
  • Published:
Tissue Engineering and Regenerative Medicine Aims and scope

Abstract

Background:

Liver inflammation is the main cause of severe liver diseases, including liver fibrosis, steatohepatitis, cirrhosis and hepatocellular carcinoma. Cell therapy topics are receiving increasingly more attention. The therapeutic applications of mesenchymal stem cells (MSC) have become one of the most discussed issues. While other stem cells have therapeutic effects, they have only one or two clinical applications. MSCs are responsible for repairing a variety of tissue injuries. Moreover, MSCs could be derived from several sources, including adipose tissue. MSCs are usually more abundant and easier to obtain compared to other stem cells.

Methods:

To prove the concept that MSCs have homing ability to the injured tissue and assist in tissue repair, we examined the effects of intravenous injected adipose-derived mesenchymal stem cells (ADSCs) in a N-nitrosodiethylamine (DEN)-induced liver injury rat model.

Results:

The significant repairing ability of ADSCs was observed. The levels of fibrosis, apoptosis, and tumorigenesis in the DEN-injured liver tissues all decreased after ADSC treatment. Furthermore, to enhance the therapeutic effects of ADSCs, we pretreated them with L-theanine, which promotes the hepatocyte growth factor secretion of ADSC, and therefore improved the healing effects on injured liver tissue.

Conclusion:

ADSCs, especially L-theanine-pretreated ADSCs, have anti-inflammation, anti-apoptosis, and anti-tumorigenesis effects on the N-nitrosodiethylamine-induced liver injury rat model.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11

Similar content being viewed by others

References

  1. Wang PL, Flemming JA. Addressing the global cirrhosis epidemic: one size will not fit all. Lancet Gastroenterol Hepatol. 2020;5:230–1.

    Article  PubMed  Google Scholar 

  2. Koyama Y, Brenner DA. Liver inflammation and fibrosis. J Clin Invest. 2017;127:55–64.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Diehl AM, Day C. Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis. N Engl J Med. 2017;377:2063–72.

    Article  PubMed  CAS  Google Scholar 

  4. Liang X, Ding Y, Zhang Y, Tse HF. Paracrine mechanisms of mesenchymal stem cell-based therapy: current status and perspectives. Cell Transplant. 2014;23:1045–59.

    Article  PubMed  Google Scholar 

  5. Leuning DG, Beijer NRM, du Fossé NA, Vermeulen S, Lievers E, van Kooten C, et al. The cytokine secretion profile of mesenchymal stromal cells is determined by surface structure of the microenvironment. Sci Rep. 2018;8:7716.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Yang X, Meng Y, Han Z, Ye F, Wei L, Zong C. Mesenchymal stem cell therapy for liver disease: full of chances and challenges. Cell Biosci. 2020;10:123.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Zhang S, Yang Y, Fan L, Zhang F, Li L. The clinical application of mesenchymal stem cells in liver disease: the current situation and potential future. Ann Transl Med. 2020;8:565.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  8. Tolba R, Kraus T, Liedtke C, Schwarz M, Weiskirchen R. Diethylnitrosamine (DEN)-induced carcinogenic liver injury in mice. Lab Anim. 2015;49:59–69.

    Article  PubMed  CAS  Google Scholar 

  9. Helms TH, Mullins RD, Thomas-Ahner JM, Kulp SK, Campbell MJ, Lucas F, et al. Inhibition of androgen/AR signaling inhibits diethylnitrosamine (DEN) induced tumour initiation and remodels liver immune cell networks. Sci Rep. 2021;11:3646.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  10. Ahn B, Han BS, Kim DJ, Ohshima H. Immunohistochemical localization of inducible nitric oxide synthase and 3-nitrotyrosine in rat liver tumors induced by N-nitrosodiethylamine. Carcinogenesis. 1999;20:1337–44.

    Article  PubMed  CAS  Google Scholar 

  11. Boitier E, Merad-Boudia M, Guguen-Guillouzo C, Defer N, Ceballos-Picot I, Leroux J, et al. Impairment of the mitochondrial respiratory chain activity in diethylnitrosamine-induced rat hepatomas: possible involvement of oxygen free radicals. Cancer Res. 1995;55:3028–35.

    PubMed  CAS  Google Scholar 

  12. Chen TS, Ju DT, Day CH, Yeh TL, Chen RJ, Viswanadha VP, et al. Protective effect of autologous transplantation of resveratrol preconditioned adipose-derived stem cells in the treatment of diabetic liver dysfunction in rat model. J Tissue Eng Regen Med. 2019;13:1629–40.

    Article  PubMed  CAS  Google Scholar 

  13. Hidese S, Ogawa S, Ota M, Ishida I, Yasukawa Z, Ozeki M, et al. Effects of L-theanine administration on stress-related symptoms and cognitive functions in healthy adults: a randomized controlled trial. Nutrients. 2019;11:2362.

    Article  PubMed Central  CAS  Google Scholar 

  14. Wu WY, Lee SP, Chiang BJ, Lin WY, Chien CT. Urothelial calcium-sensing receptor modulates micturition function via mediating detrusor activity and ameliorates bladder hyperactivity in rats. Pharmaceuticals (Basel). 2021;14:960.

    Article  CAS  Google Scholar 

  15. Chung SD, Lai TY, Chien CT, Yu HJ. Activating Nrf-2 signaling depresses unilateral ureteral obstruction-evoked mitochondrial stress-related autophagy, apoptosis and pyroptosis in kidney. PLoS One. 2012;7:e47299.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  16. Chen TS, Liao WY, Huang CW, Chang CH. Adipose-derived stem cells preincubated with green tea EGCG enhance pancreatic tissue regeneration in rats with type 1 diabetes through ROS/Sirt1 signaling regulation. Int J Mol Sci. 2022;23:3165.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  17. Bai DS, Zhang C, Chen P, Jin SJ, Jiang GQ. The prognostic correlation of AFP level at diagnosis with pathological grade, progression, and survival of patients with hepatocellular carcinoma. Sci Rep. 2017;7:12870.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Nakamura T, Mizuno S. The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine. Proc Jpn Acad Ser B Phys Biol Sci. 2010;86:588–610.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  19. Forte G, Minieri M, Cossa P, Antenucci D, Sala M, Gnocchi V, et al. Hepatocyte growth factor effects on mesenchymal stem cells: proliferation, migration, and differentiation. Stem Cells. 2006;24:23–33.

    Article  PubMed  CAS  Google Scholar 

  20. Song P, Han T, Xiang X, Wang Y, Fang H, Niu Y, et al. The role of hepatocyte growth factor in mesenchymal stem cell-induced recovery in spinal cord injured rats. Stem Cell Res Ther. 2020;11:178.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  21. Yang Y, Chen QH, Liu AR, Xu XP, Han JB, Qiu HB. Synergism of MSC-secreted HGF and VEGF in stabilising endothelial barrier function upon lipopolysaccharide stimulation via the Rac1 pathway. Stem Cell Res Ther. 2015;6:250.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Latief U, Ahmad R. β-carotene inhibits NF-kappaB and restrains diethylnitrosamine-induced hepatic inflammation in Wistar rats. Int J Vitam Nutr Res. 2020:1–10.

  23. Nozaki Y, Hikita H, Tanaka S, Fukumoto K, Urabe M, Sato K, et al. Persistent hepatocyte apoptosis promotes tumorigenesis from diethylnitrosamine-transformed hepatocytes through increased oxidative stress, independent of compensatory liver regeneration. Sci Rep. 2021;11:3363.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  24. Wree A, Johnson CD, Font-Burgada J, Eguchi A, Povero D, Karin N, et al. Hepatocyte-specific Bid depletion reduces tumor development by suppressing inflammation-related compensatory proliferation. Cell Death Differ. 2015;22:1985–94.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  25. Serhal R, Saliba N, Hilal G, Moussa M, Hassan GS, Atat OE, et al. Effect of adipose-derived mesenchymal stem cells on hepatocellular carcinoma: in vitro inhibition of carcinogenesis. World J Gastroenterol. 2019;25:567–83.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  26. Abdel aziz MT, El Asmar MF, Atta HM, Mahfouz S, Fouad HH, Roshdy NK, et al. Efficacy of mesenchymal stem cells in suppression of hepatocarcinorigenesis in rats: possible role of Wnt signaling. J Exp Clin Cancer Res. 2011;30:49.

  27. Sato K, Tanaka M, Kusaba T, Fukuda H, Tanikawa K. Immunohistochemical demonstration of alpha-fetoprotein in small hepatocellular carcinoma. Oncol Rep. 1998;5:355–8.

    PubMed  CAS  Google Scholar 

  28. Baraniak PR, McDevitt TC. Stem cell paracrine actions and tissue regeneration. Regen Med. 2010;5:121–43.

    Article  PubMed  Google Scholar 

  29. de Miguel-Gómez L, Ferrero H, López-Martínez S, Campo H, López- Pérez N, Faus A, et al. Stem cell paracrine actions in tissue regeneration and potential therapeutic effect in human endometrium: a retrospective study. BJOG. 2020;127:551–60.

    Article  PubMed  Google Scholar 

  30. Choi JS, Park YJ, Kim SW. Three-dimensional sifferentiated human mesenchymal stem cells exhibit robust antifibrotic potential and ameliorates mouse liver fibrosis. Cell Transplant. 2021;30:963689720987525.

    Article  PubMed  Google Scholar 

  31. Moon SH, Lee CM, Park SH, Nam MJ. Effects of hepatocyte growth factor gene-transfected mesenchymal stem cells on dimethylnitrosamine-induced liver fibrosis in rats. Growth Factors. 2019;37:105–19.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

We thank Instrumentation Center (National Taiwan Normal University) for the image acquisition and flow cytometry analysis. This work was partly supported from MOST-106-2320-B-003-002 -MY3 (Dr. Chiang-Ting Chien), MOST-105-2320-B-003-007 (Dr. Yun-Ju Lai) and NTUS-innovation cooperation 10912041004 (Dr. Yun-Ju Lai).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Tung-Sheng Chen or Chiang-Ting Chien.

Ethics declarations

Conflict of interest

The authors of this study state that there is no conflict of interests in this study.

Ethical statement

All surgical and experimental procedures were approved by National Taiwan Normal University Institutional Animal Care and Use Committee (Approval number 105035) and were in accordance with the guidelines of the National Science Council of Republic of China (NSC 1997).

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 14 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lai, YJ., Sung, YT., Lai, YA. et al. L-Theanine-Treated Adipose-Derived Mesenchymal Stem Cells Alleviate the Cytotoxicity Induced by N-Nitrosodiethylamine in Liver. Tissue Eng Regen Med 19, 1207–1221 (2022). https://doi.org/10.1007/s13770-022-00472-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13770-022-00472-2

Keywords

Navigation